Prognostic utility of 19Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT

Journal of Nuclear Medicine

Volumn 54, Issue 12, 2013, Pages 2055-2061

  Lam, Marnix G E H ^a,b   Goris, Michael L ^a   Iagaru, Andrei H ^a   Mittra, Erik S ^a   Louie, John D ^a   Sze, Daniel Y ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Colorectal carcinoma; Dosimetry; Hepatic metastases; Radioembolization; Treatment planning

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARCINOEMBRYONIC ANTIGEN; HEMOGLOBIN; MACROSALB TC 99M; TECHNETIUM SULFUR COLLOID TC 99M; YTTRIUM 90; YTTRIUM; DIAGNOSTIC AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COLORECTAL CARCINOMA; DIAGNOSTIC TEST ACCURACY STUDY; DOSE LIVER FUNCTION RELATION; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER TOXICITY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOEMBOLIZATION; RADIOISOTOPE DISTRIBUTION; RECEIVER OPERATING CHARACTERISTIC; RETICULOENDOTHELIAL SYSTEM; SENSITIVITY AND SENSIBILITY; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING; ARTIFICIAL EMBOLISM; BLOOD; COLORECTAL TUMOR; DIAGNOSTIC USE; IMAGE PROCESSING; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOMETRY; SCINTISCANNING; SECONDARY; VERY ELDERLY; HEPATIC METASTASES; LIVER TUMOR; METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIOMETRY; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M SULFUR COLLOID; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YTTRIUM RADIOISOTOPES;

COLORECTAL CARCINOMA; DOSIMETRY; HEPATIC METASTASES; RADIOEMBOLIZATION; TREATMENT PLANNING;

EID: 84893427718     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.123257     Document Type: Article

References (20)

1. Coldwell D, Sangro B, Salem R, et al. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers. Am J Clin Oncol. 2012;35:167-177.
2. Sangro B, Salem R, Kennedy A, et al. Radioembolization for hepatocellular carcinoma: a review of the evidence and treatment recommendations. Am J Clin Oncol. 2011;34:422-431.
3. Sangro B, Carpanese L, Cianni R, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology. 2011;54:868-878.
4. Vente MA, Wondergem M, van de Tweel I, et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol. 2009;19:951-959.
5. Dezarn WA, Cessna JT, de Werd LA, et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys. 2011;38:4824-4845.
6. Gulec SA, Mesoloras G, Stabin M. Dosimetric techniques in 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med. 2006;47:1209-1211.
7. Kao YH, Hock Tan AE, Burgmans MC, et al. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. J Nucl Med. 2012;53:559-566.
8. Garin E, Lenoir L, Rolland Y, et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med. 2012;53:255-263.
9. Strigari L, Sciuto R, Rea S, et al. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations. J Nucl Med. 2010;51:1377-1385.
10. Lau WY, Kennedy AS, Kim YH, et al. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys. 2012;82:401-407.
11. Coldwell D, Sangro B, Wasan H, et al. General selection criteria of patients for radioembolization of liver tumors: an international working group report. Am J Clin Oncol. 2011;34:337-341.
12. Lewandowski RJ, Sato KT, Atassi B, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007;30:571-592.
13. Kennedy A, Nag S, Salem R, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68:13-23.
14. Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase 2 trial of SIRSpheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/ leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004;88:78-85.
15. Kennedy AS, McNeillie P, Dezarn WA, et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys. 2009;74:1494-1500.
16. Sangro B, Gil-Alzugaray B, Rodriguez J, et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer. 2008;112:1538-1546.
17. Lawrence TS, Robertson JM, Anscher MS, et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31:1237-1248.
18. Gray B, van Hazel G, Hope M, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001;12:1711-1720.
19. Kao YH, Tan EH, Ng CE, et al. Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review. Ann Nucl Med. 2011;25:455-461.
20. Rubin RA, Lichtenstein GR. Hepatic scintigraphy in the evaluation of solitary solid liver masses. J Nucl Med. 1993;34:697-705.